Skip to main content
. 2008 Dec 24;16(3):303–311. doi: 10.1128/CVI.00372-08

TABLE 3.

Overall summary results of estimates, with 95% confidence limits, for samples A to D (IgA) in terms of units of U.S. lot 5a

Antibody and assay Estimates as units of U.S. reference lot 5 under sample code:
Estimates for B and C as equivalent ml of A and D Estimates for B and C in terms of Ab Proposed IU for A and D (06/140 and 06/146)
A (06/140) D (06/146) B (06/142) C (06/144)
IgA anti-PT ELISA 63.0 (49.8-79.7) [8] 62.4 (48.8-77.1) [8] 20.4 (13.5-30.9) [8] 20.1 (13.1-30.8) [8] 0.32 (0.22-0.48) [8] 21.1 (14.3-30.9) [8] NAc
IgA anti-PT (omit lab 21) 65.3 (50.3-84.8) [7] 63.8 (49.7-81.9) [7] 18.4 (12.4-27.3) [7] 18.2 (11.9-27.9) [7] 0.28 (0.22-0.35) [7] 18.3 (14.5-23.1) [7] 65
IgA anti-FHA ELISA 70.5 (54.5-91.3) [8] 68.0 (53.8-85.8) [8] 90.7 (74.3-110.8) [8] 87.6 (73.3-104.8) [8] 1.30 (1.21-1.39) [8] 84.2 (78.5-90.4) [8] NA
IgA anti-FHA (omit lab 21) 65.7 (52.0-83.0) [7] 63.3 (52.3-76.5) [7] 86.7 (70.9-105.9) [7] 83.3 (71.0-97.7) [7] 1.33 (1.26-1.39) [7] 86.3 (82.2-90.6) [7] 65
IgA anti-PRN ELISA 42.8 (34.6-52.9) [5] 41.9 (37.1-47.5) [5] 37.5 (33.6-41.8) [5] 38.5 (33.8-43.7) [5] 0.90 (0.76-1.06) [5] 37.6 (31.9-44.3) [5] 42
a

The 95% confidence limits are given in parentheses. The numbers of estimates (one estimate per laboratory) combined are indicated in brackets.

b

Using proposed IU for sample A.

c

NA, not applicable.